SEC Form 4 · accession 0001645470-19-000005
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan Brian Collier
Officer — CEO
Period of report
Jan 17, 2019
Accepted (ET)
Jan 23, 2019 · 3:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 17, 2019 | P | 5,000 | $0.0297 | A | 20,812,623 | D | |
| Common Stock | Jan 17, 2019 | P | 5,000 | $0.0295 | A | 20,817,623 | D | |
| Common Stock | Jan 17, 2019 | P | 5,000 | $0.0295 | A | 20,822,623 | D | |
| Common Stock | Jan 22, 2019 | P | 500 | $0.0259 | A | 20,823,123 | D | |
| Common Stock | Jan 22, 2019 | P | 10,000 | $0.026 | A | 20,833,123 | D | |
| Common Stock | Jan 22, 2019 | P | 5,000 | $0.0259 | A | 20,838,123 | D | |
| Common Stock | Jan 22, 2019 | P | 5,000 | $0.0259 | A | 20,843,123 | D | |
| Common Stock | Jan 22, 2019 | P | 5,000 | $0.0259 | A | 20,848,123 | D | |
| Common Stock | Jan 22, 2019 | P | 5,000 | $0.027 | A | 20,853,123 | D | |
| Common Stock | Jan 22, 2019 | P | 10,000 | $0.0267 | A | 20,863,123 | D | |
| Common Stock | Jan 22, 2019 | P | 5,000 | $0.0267 | A | 20,868,123 | D | |
| Common Stock | Jan 22, 2019 | P | 5,000 | $0.0267 | A | 20,873,123 | D |
Table II — derivative securities
No Table II lines on this filing.